Article

Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in Argentina

2020-10-23

Abstract excerpt

<h4>ABSTRACT</h4> We report the emergency development and application of a robust serologic test to evaluate acute and convalescent antibody responses to SARS-CoV-2 in Argentina. The assays, COVIDAR IgG and IgM, which were produced and provided for free to health authorities, private and public health institutions and nursing homes, use a combination of a trimer stabilized spike protein and the receptor binding do...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e684c408-4133-516c-b827-9ccb9c7af926
DOI: 10.1101/2020.10.21.20216960

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaDOI 10.1101/2020.10.21.20216960Read

Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in ArgentinaSemantic proximity Read

Persistent Levels of Anti-SARS-CoV-2 IgM Antibody Measured by an In-house ELISA in a Convalescent Latin Population Positively Correlate with the Neutralizing Percentages to Several Variants of ConcernSemantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severitySemantic proximity Read

Antibody kinetics to SARS-CoV-2 at 13.5 months, by disease severitySemantic proximity Read

A comprehensive antigen production and characterization study for easy-to-implement, highly specific and quantitative SARS-CoV-2 antibody assaysSemantic proximity Read

Analysis of IgG, IgA, and IgM antibodies against SARS-CoV-2 spike protein S1 in convalescent and vaccinated patients with the Pfizer-BioNTech and CanSinoBio vaccinesSemantic proximity Read

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read

Performance, Dynamic Change and Clinical Relevance of SARS-CoV-2 Antibody ResponsesSemantic proximity Read

Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity Read

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity Read

Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2Semantic proximity Read